WHO Expert Committee on Biological Standardization [meeting held in Geneva from 1 to 8 December 1986] : thirty-seventh report.
Material type: TextSeries: World Health Organization technical report series ; no. 760Publication details: Geneva : World Health Organization, 1987. Description: 203 pISBN: 9241207604Title translated: Comité OMS d' experts de la standardisation biologique [réuni à Genève du 1 au 8 décembre 1986] : trente-septième rapport; Comité de Expertos de la OMS en Patrones Biológicos [se reunió en Ginebra del 1 al 8 de diciembre de 1986] : 37o informeSubject(s): Biological products -- standards | Pharmacology, Toxicology and Clinical TechnologyNLM classification: QW 800Online resources: Click here to access online | Click here to access online | Click here to access online | Click here to access online Abstract: Announces changes in the status or development of international standards for 35 biologicals, classified as antibiotics, antibodies, antigens, blood products and related substances, endocrinological and related substances, and a miscellaneous group of substances. The report also provides detailed information on requirements for the manufacturing, testing, and quality control of selected vaccines, including hepatitis B vaccines made by recombinant DNA techniques in yeast, live mumps vaccine, and inactivated rabies vaccine produced in continuous cell lines. Of particular practical interest is an extensive report on a WHO meeting concerned with the use of recombinant DNA techniques to produce hepatitis B vaccines. The report also includes amendments to previous requirements for oral poliomyelitis vaccine and for diphtheria toxoid, pertussis vaccine, tetanus toxoid, and combined vaccines.Item type | Current library | Call number | Copy number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Books | WHO HQ READING-RM | HQ SERIAL (Browse shelf(Opens below)) | 1 | Available | 00009612 | |
Books | WHO HQ READING-RM | HQ SERIAL RUS (Browse shelf(Opens below)) | 1 | Available | 00029855 | |
Books | WHO HQ ONLINE-IRIS | HQ SERIAL RUS (Browse shelf(Opens below)) | 2 | Available | O9241207604RUS | |
Books | WHO HQ BORROWABLE-COLL-STACKS | QW 800 87WH-3 (Browse shelf(Opens below)) | 2 | Withdrawn | 00009613 | |
Books | WHO HQ ONLINE-IRIS | QW 800 87WH-3 (Browse shelf(Opens below)) | 3 | Available | O9241207604 |
Browsing WHO HQ shelves, Shelving location: READING-RM Close shelf browser (Hides shelf browser)
Announces changes in the status or development of international standards for 35 biologicals, classified as antibiotics, antibodies, antigens, blood products and related substances, endocrinological and related substances, and a miscellaneous group of substances. The report also provides detailed information on requirements for the manufacturing, testing, and quality control of selected vaccines, including hepatitis B vaccines made by recombinant DNA techniques in yeast, live mumps vaccine, and inactivated rabies vaccine produced in continuous cell lines. Of particular practical interest is an extensive report on a WHO meeting concerned with the use of recombinant DNA techniques to produce hepatitis B vaccines. The report also includes amendments to previous requirements for oral poliomyelitis vaccine and for diphtheria toxoid, pertussis vaccine, tetanus toxoid, and combined vaccines.
eng fre rus spa.
WHODOC
WHO monograph
4
There are no comments on this title.